Related references
Note: Only part of the references are listed.Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases
Vitaly I. Loginov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers
Nicole Gull et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
miR-182-5p Inhibits NKAPL Expression and Promotes the Proliferation of Osteosarcoma
Shen Yang et al.
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation
Daniela Mancarella et al.
GENOME MEDICINE (2021)
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
Milena Hornburg et al.
CANCER CELL (2021)
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer
Romina Silva et al.
CLINICAL EPIGENETICS (2021)
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
Tianzhi Wu et al.
INNOVATION (2021)
The untapped potential of ascites in ovarian cancer research and treatment
Caroline Elizabeth Ford et al.
BRITISH JOURNAL OF CANCER (2020)
ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple-negative breast cancer
Xiaoyu Zhang et al.
CELL BIOLOGY INTERNATIONAL (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Michael-Antony Lisio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N. Colombo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
Ilaria Alborelli et al.
CELL DEATH & DISEASE (2019)
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
S. Venkatesan et al.
ANNALS OF ONCOLOGY (2018)
Hypermethylation of NF-kappa B-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis
Patrick Kwok Shing Ng et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
Lea Kristin Roever et al.
EBIOMEDICINE (2018)
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Olga Kondrashova et al.
NATURE COMMUNICATIONS (2018)
Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts
Mohammed Moquitul Haque et al.
SCIENTIFIC REPORTS (2018)
Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs
Fang Fang et al.
CANCER RESEARCH (2018)
Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer
James M. Flanagan et al.
CLINICAL CANCER RESEARCH (2017)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
Diane Goltz et al.
ONCOTARGET (2017)
DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
Riikka J. Lund et al.
SCIENTIFIC REPORTS (2017)
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
Tushar Tomar et al.
BMC MEDICINE (2017)
missMethyl: an R package for analyzing data from Illumina's HumanMethylation450 platform
Belinda Phipson et al.
BIOINFORMATICS (2016)
Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions
Sumiyo Morita et al.
NATURE BIOTECHNOLOGY (2016)
Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
Tushar Tomar et al.
GENOME MEDICINE (2016)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
Kin Chan et al.
NATURE GENETICS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
A Novel Transcriptional Factor Nkapl Is a Germ Cell-Specific Suppressor of Notch Signaling and Is Indispensable for Spermatogenesis
Hidenobu Okuda et al.
PLOS ONE (2015)
De novo identification of differentially methylated regions in the human genome
Timothy J. Peters et al.
EPIGENETICS & CHROMATIN (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
Notch signaling in serous ovarian cancer
Jolijn W. Groeneweg et al.
JOURNAL OF OVARIAN RESEARCH (2014)
DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns
Kaie Lokk et al.
GENOME BIOLOGY (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases
Atsushi Koito et al.
FRONTIERS IN MICROBIOLOGY (2013)
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Olafur A. Stefansson et al.
EPIGENETICS (2012)
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
C. Zeller et al.
ONCOGENE (2012)
Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
Barbara Norquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
Euan A. Stronach et al.
NEOPLASIA (2011)
Primer design versus PCR bias in methylation independent PCR amplifications
Tomasz K. Wojdacz et al.
EPIGENETICS (2009)
Reversal of PCR bias for improved sensitivity of the DNA methylation melting curve assay
Tomasz K. Wojdacz et al.
BIOTECHNIQUES (2006)
Share Paper
